EKF
NEUTRALEKF Diagnostics Announces Share Buyback Extension
The healthcare diagnostics company has extended its share buyback program to repurchase up to an additional £1 million of its own shares.
EKF Diagnostics Holdings
25.10GBX
-3.46%
Market Cap
116.56M
Volume
68.63k
13% of avg
P/E Ratio
17.31
EPS (TTM)
1.45
Beta
0.59
Day Range
25.10p - 26.00p
52 Week Range
18.40p25.10p32.00p
25.10p
Upcoming Events
31 December 2025
FY 2025 Results
High Impact Event
Early 2026
Full Year 2025 Results expected
High Impact Event
EKF
NEUTRALEKF Diagnostics Announces Share Buyback
The healthcare diagnostics company has purchased over 700,000 of its own shares as part of an ongoing buyback program.
EKF
NEUTRALEKF Diagnostics Announces Director Dealings
The healthcare company has announced changes to its major shareholders.
EKF
NEUTRALEKF Diagnostics Grants CEO Long Term Incentive Award
The healthcare diagnostics company has granted its CEO a long-term incentive award, linking his pay to the firm's adjusted EBITDA growth.
EKF
GOODEKF Diagnostics Reports Improved Profitability and Strong Cash Position in H1 2025
The medical diagnostics firm reported improved profitability and a strong cash position in H1 2025, with adjusted EBITDA up 7.4% and profit before tax rising 16.1%, despite flat revenue growth.
EKF
NEUTRALEKF Diagnostics Announces Interim Results Presentation
The diagnostics company will be hosting an online presentation to discuss its interim results for the six months ended 30 June 2025.
EKF
VERY GOODEKF Diagnostics Secures €4.65m in Hematology Contracts Across Latin America and Africa
The healthcare diagnostics company has secured €4.65m in new Hematology contracts across Latin America and Africa, reinforcing its growth outlook.
EKF
GOODEKF Diagnostics Reports Continued Earnings Growth in H1 2025
The healthcare diagnostics company reports improved earnings and cash generation in the first half of 2025, with continued investment for future growth.
EKF
NEUTRALEKF Diagnostics Cancels Treasury Shares
The diagnostics company has cancelled a number of treasury shares and provided an update on its total voting rights.
EKF
NEUTRALEKF Diagnostics Announces Change in Shareholding
The healthcare company has announced a change in its shareholder structure.